期刊文献+

基于核因子-κB信号通路分析补肾活血祛湿中药治疗膝关节骨性关节炎的作用机制 被引量:3

Analysis in mechanism of tradition Chinese medicine for tonifying kidney,activating blood circulation and removing dampness in treatment of knee osteoarthritis based on nuclear factor-κB signal pathway
下载PDF
导出
摘要 目的基于核因子-κb(NF-κB)信号通路分析补肾活血祛湿中药治疗膝关节骨性关节炎(KOA)的作用机制。方法对模型对照组、地塞米松组、补肾活血祛湿中药各剂量组(中药低剂量组、中药高剂量组)大鼠采用前交叉韧带横断术(ACLT)建立KOA模型。正常对照组大鼠无任何操作;地塞米松组、中药低剂量组、中药高剂量组在造模成功第1天开始给予相应剂量(依次为50、50、100 mg/kg)的药物灌胃,持续给予4周;正常对照组和模型对照组给予等体积生理盐水。实验结束后,测定大鼠缩爪热潜伏期(PWTL)、Mankin′s评分。采用酶联免疫吸附法测定血清白细胞介素-4(IL-4)、白细胞介素-1b(IL-1b)和肿瘤坏死因子-α(TNF-α)水平;采用逆转录聚合酶链式反应(RT-PCR)法及蛋白印记法测定膝关节滑膜组织微小RNA-26a(miR-26a)、NF-κB、toll样受体4(TRL4)水平。结果与正常对照组比较,模型对照组PWTL缩短,Mankin′s评分(中药低剂量组除外)、IL-1b、IL-4、TNF-α以及miR-26a、NF-κB、TRL4的mRNA、蛋白表达水平延长,差异有统计学意义(P<0.05)。与模型对照组比较,中药低剂量组、中药高剂量组、地塞米松组PWTL延长,Mankin′s评分(中药低剂量组除外)、IL-1b、IL-4、TNF-α以及miR-26a、NF-κB、TRL4的mRNA、蛋白表达水平降低,且中药高剂量组PWTL长于中药低剂量组,Mankin′s评分、IL-1b、IL-4、TNF-α以及miR-26a、NF-κB、TRL4的mRNA、蛋白表达水平低于中药低剂量组,差异均有统计学意义(P<0.05)。与地塞米松组比较,中药低剂量组PWTL缩短,Mankin′s评分、IL-1b、IL-4、TNF-α以及miR-26a、NF-κB、TRL4的mRNA、蛋白表达水平升高,差异有统计学意义(P<0.05)。与地塞米松组比较,中药高剂量组PWTL轻微缩短,Mankin′s评分、IL-1b、IL-4、TNF-α以及miR-26a、NF-κB、TRL4的mRNA、蛋白表达水平轻微升高,差异均无统计学意义(P>0.05)。结论补肾活血祛湿中药能显著抑制KOA炎症反应,其机制可能与抑制miR-26a mRNA、NF-κB mRNA、TRL4 mRNA表达水平以及抑制miR-26a/NF-κB/TRL4通路的激活有关。 Objective To analyze the mechanism of tradition Chinese medicine for tonifying kidney,activating blood circulation and removing dampness in the treatment of knee osteoarthritis(KOA)based on nuclear factor-κB(NF-κB)signal pathway.Methods KOA model was established by anterior cruciate ligament transection(ACLT)in the rats of model control group,dexamethasone group,and groups with various doses of traditional Chinese medicine for tonifying the kidney,activating blood circulation and removing dampness(low dose of traditional Chinese medicine group and high dose of traditional Chinese medicine group).No operation was given for rats in the normal control group;the dexamethasone group,the low dose of traditional Chinese medicine group and the high dose of traditional Chinese medicine group were given corresponding doses of drugs for gavage(50,50 and 100 mg/kg)on the first day,and the gavage was lasted for 4 weeks;normal control group and model control group were given equal volume of normal saline.When the experiment was over,the paw withdrawal thermal latency(PWTL)and Mankin′s score of rats were measured.Levels of serum interleukin-4(IL-4),interleukin-1b(IL-1b)and tumor necrosis factor-α(TNF-α)were measured by enzyme-linked immunosorbent assay;the levels of microRNA-26a(miR-26a),NF-κB and toll-like receptor 4(TRL4)in synovial tissues of knee joints were determined by reverse transcriptase polymerase chain reaction(RT-PCR)and western blot.Results Compared with the normal control group,PWTL in the model control group shortened significantly,while the Mankin′s score,IL-1b,IL-4,TNF-αand mRNA and protein expression levels of miR-26a,NF-κB and TRL4 prolonged significantly(P<0.05).Compared with the model control group,PWTL prolonged significantly,while the Mankin′s score(except for the low dose of traditional Chinese medicine group),IL-1b,IL-4,TNF-αand mRNA and protein expression levels of miR-26a,NF-κB and TRL4 decreased significantly in the low dose of traditional Chinese medicine group,high dose of traditional Chinese medicine group and dexamethasone group,and PWTL in high dose of traditional Chinese medicine group was significantly longer than that in the low dose of traditional Chinese medicine group,while the Mankin′s score,IL-1b,IL-4,TNF-αand mRNA and protein expression levels of miR-26a,NF-κB and TRL4 were significantly lower than those in low dose of traditional Chinese medicine group(P<0.05).Compared with dexamethasone group,PWTL shortened significantly,while the Mankin′s score,IL-1b,IL-4,TNF-αand mRNA and protein expression levels of miR-26a,NF-κB and TRL4 increased significantly in low dose of traditional Chinese medicine group(P<0.05).Compared with dexamethasone group,PWTL shortened slightly while the Mankin′s score,IL-1b,IL-4,TNF-αand mRNA and protein expression levels of miR-26a,NF-κB and TRL4 increased slightly in high dose of traditional Chinese medicine group,and there were no significant differences between two groups(P>0.05).Conclusion Tradition Chinese medicine for tonifying kidney,activating blood circulation and removing dampness can significantly inhibit the inflammatory response of KOA,and its mechanism may be related to the inhibition on expression levels of miR-26a mRNA,NF-κB mRNA and TRL4 mRNA,and inhibition on activation of miR-26a/NF-κB/TRL4 pathway.
作者 莫志生 徐培青 李桓宇 滑国田 程戴维 扈自然 MO Zhisheng;XU Peiqing;LI Huanyu;HUA Guotian;CHENG Daiwei;HU Ziran(First Department of Bone Trauma,Shenzhen Hospital(Longgang)of Beijing University of Traditional Chinese Medicine,Shenzhen,Guangdong,518100)
出处 《实用临床医药杂志》 CAS 2022年第11期87-93,99,共8页 Journal of Clinical Medicine in Practice
基金 广东省深圳市龙岗区2019年度医疗卫生科技计划项目(LGKCYLWS2019000427)。
关键词 微小RNA-26a TOLL样受体4 核因子-ΚB 补肾活血祛湿中药 膝关节骨性关节炎 microRNA-26a toll-like receptor 4 nuclear factor-κB traditional Chinese medicine for tonifying kidney,activating blood circulation and removing dampness knee osteoarthritis
  • 相关文献

参考文献4

二级参考文献55

  • 1Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis [J]. Ann Rheum Dis, 1963, 22:237 -255.
  • 2Huskisson EC. Measurement of pain [J]. Lancet, 1974, 2(7889) : 1127 -1131.
  • 3Insall JN, Dorr LD, Scott RD, et al. Rationale of the knee society clinical rating system [ J]. Clin Orthop Relat Res, 1989,248 : 13 - 14.
  • 4Lequesne MG, Mery C, Samson M, et al. Indexes of severity for oste- oarthritis of the hip and knee. Validation - value in comparison withother assessment tests [ J ]. Scand J Rheumatol Suppl, 1987,65:85 - 89.
  • 5Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC : a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee [ J]. J Rheumatol, 1985, 15 (12) :1833 - 1840.
  • 6Bannuru RR, Natov NS, Ohadan IE, et al. Therapeutic trajectory of hyaluronic acid versus cortieosteroids in the treatment of knee osteoar- thritis: a systematic review and metaanalysis [ J]. Arthritis Rheum, 2009, 61(12) :1704 -1711.
  • 7Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hips and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research pub- lished through January 2009 [J]. Osteoarthritis Cartilage, 2010,18 (4) :476 -499.
  • 8McAlindon Te, Bannuru RR. OARSI recommendations for the man- agement of hips and knee osteoarthritis: the semantics of differences and changes [J]. Osteoarthritis Cartilage, 2010, 18(4) : 473 -475.
  • 9Jorgensen A, Stengaard - Pedersen K, Simonsen O, et al. Intra - ar- ticular hyaluronan is without clinical effect in knee osteoarthritis: a multicenter, randomized, placebo- controlled, double- blind study of 337 patients followed for 1 year [J]. Ann Rheum Dis, 2010, 69 (6) :1097 - 1102.
  • 10Jevsevar DS, Brown GA, Jones DL, et al. The American Academy of Orthopaedic Surgeons evidence - based guideline on: treatment of os- teoarthritis of the knee, 2nd edition [ J]. The Journal of Bone and Joint Surgery: American, 2013, 95(20) :1885 -1886.

共引文献102

同被引文献42

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部